ICYMI: Catch up on Prime’s educational sessions from AMCP 2025 - Prime Therapeutics
ICYMI: Catch up on Prime’s educational sessions from AMCP 2025
Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service
With more than 6,000 managed care pharmacy professionals in attendance, the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston was the place for the latest health care insights and trends.
But if you couldn’t be there, we have you covered.
I (Alex Cook, part of Prime’s newsroom team) caught up with the Prime Therapeutics (Prime) researchers who presented educational sessions at AMCP. Tune into the interviews from the latest Pharmacy Friends podcast below.
55:22: “Legislative Impacts on Site of Service: What is the Big Deal?” with Sean Shirk, senior specialty clinical solutions director at Prime, and Connie Estep, senior specialty clinical solutions director at Prime
15:56: “Accelerated Approvals, Where Are We Now?” with Sneha Sharma, director, specialty clinical solutions at Prime, Soumya Vishwanath, formulary management director at Prime, and Timothy O’Shea, director of Specialty Pharmacy with Horizon Blue Cross Blue Shield of New Jersey
50:32: “Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge” with Rachel Prusi, senior specialty clinical solutions director at Prime
For more insights from AMCP, visit the Prime newsroom.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.